10 20 30 40 50 60 70 80 2O2F - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER APOPTOSIS 29-NOV-06 2O2F
TITLE SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN TITLE 2 COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B
KEYWDS APOPTOSIS, COMPLEX, BCL, NMR
EXPDTA SOLUTION NMR
AUTHOR M.BRUNCKO,T.K.OOST,B.A.BELLI,H.DING,M.K.JOSEPH,A.KUNZER, AUTHOR 2 D.MARTINEAU,W.J.MCCLELLAN,M.MITTEN,S.C.NG,P.M.NIMMER, AUTHOR 3 T.OLTERSDORF,C.M.PARK,A.M.PETROS,A.R.SHOEMAKER,X.SONG, AUTHOR 4 X.WANG,M.D.WENDT,H.ZHANG,S.W.FESIK,S.H.ROSENBERG,S.W.ELMORE
REVDAT 2 24-FEB-09 2O2F 1 VERSN REVDAT 1 27-FEB-07 2O2F 0
JRNL AUTH M.BRUNCKO,T.K.OOST,B.A.BELLI,H.DING,M.K.JOSEPH, JRNL AUTH 2 A.KUNZER,D.MARTINEAU,W.J.MCCLELLAN,M.MITTEN,S.C.NG, JRNL AUTH 3 P.M.NIMMER,T.OLTERSDORF,C.M.PARK,A.M.PETROS, JRNL AUTH 4 A.R.SHOEMAKER,X.SONG,X.WANG,M.D.WENDT,H.ZHANG, JRNL AUTH 5 S.W.FESIK,S.H.ROSENBERG,S.W.ELMORE JRNL TITL STUDIES LEADING TO POTENT, DUAL INHIBITORS OF JRNL TITL 2 BCL-2 AND BCL-XL. JRNL REF J.MED.CHEM. V. 50 641 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17256834 JRNL DOI 10.1021/JM061152T
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER A. T. ETALL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2O2F COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-06. REMARK 100 THE RCSB ID CODE IS RCSB040601.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 8.0 REMARK 210 IONIC STRENGTH : 25 MM TRIS; 150 MM SODIUM REMARK 210 CHLORIDE REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 25MM TRIS BUFFER; 150 MM REMARK 210 SODIUM CHLORIDE; 90% H2O, 10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ, 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 17 30.63 -94.10 REMARK 500 TYR A 26 -163.39 -162.59 REMARK 500 TRP A 28 170.91 75.65 REMARK 500 ASP A 29 143.76 -179.50 REMARK 500 TYR A 105 54.52 -99.59 REMARK 500 PHE A 121 169.05 -47.30 REMARK 500 PHE A 135 57.89 -93.69 REMARK 500 ARG A 161 32.78 -98.10 REMARK 500 MET A 163 40.78 -144.07 REMARK 500 ARG A 180 32.62 -166.76 REMARK 500 HIS A 181 -57.52 -171.40 REMARK 500 ASN A 189 51.26 -95.09 REMARK 500 LEU A 198 -70.36 -79.56 REMARK 500 TYR A 199 67.67 -107.75 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI0 A 1000
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2O1Y RELATED DB: PDB REMARK 900 RELATED ID: 2O21 RELATED DB: PDB REMARK 900 RELATED ID: 2O22 RELATED DB: PDB
DBREF 2O2F A 6 29 UNP P10415 BCL2_HUMAN 8 31 DBREF 2O2F A 89 201 UNP P10415 BCL2_HUMAN 92 204
SEQADV 2O2F GLU A 48 UNP P10415 CLONING ARTIFACT
SEQRES 1 A 138 GLY TYR ASP ASN ARG GLU ILE VAL MET LYS TYR ILE HIS SEQRES 2 A 138 TYR LYS LEU SER GLN ARG GLY TYR GLU TRP ASP GLU VAL SEQRES 3 A 138 VAL HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER SEQRES 4 A 138 ARG ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN SEQRES 5 A 138 LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA SEQRES 6 A 138 THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP SEQRES 7 A 138 GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET SEQRES 8 A 138 CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL SEQRES 9 A 138 ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG SEQRES 10 A 138 HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP SEQRES 11 A 138 ALA PHE VAL GLU LEU TYR GLY PRO
HET LI0 A1000 88
HETNAM LI0 4-(4-BENZYL-4-METHOXYPIPERIDIN-1-YL)-N-[(4-{[1,1- HETNAM 2 LI0 DIMETHYL-2-(PHENYLTHIO)ETHYL]AMINO}-3-NITROPHENYL) HETNAM 3 LI0 SULFONYL]BENZAMIDE
FORMUL 2 LI0 C36 H40 N4 O6 S2
HELIX 1 1 ASP A 8 TYR A 16 1 9 HELIX 2 2 HIS A 18 GLN A 23 1 6 HELIX 3 3 VAL A 90 TYR A 105 1 16 HELIX 4 4 TYR A 105 THR A 119 1 15 HELIX 5 5 THR A 122 PHE A 135 1 14 HELIX 6 6 ASN A 140 ARG A 161 1 22 HELIX 7 7 GLU A 162 SER A 164 5 3 HELIX 8 8 PRO A 165 ASN A 179 1 15 HELIX 9 9 HIS A 181 ASN A 189 1 9 HELIX 10 10 GLY A 190 TYR A 199 1 10
SITE 1 AC1 12 ALA A 97 ASP A 100 TYR A 105 ASP A 108 SITE 2 AC1 12 MET A 112 VAL A 130 LEU A 134 TRP A 141 SITE 3 AC1 12 GLY A 142 VAL A 145 ALA A 146 TYR A 199
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000